FDA Introduces AI Platform to Accelerate Scientific Reviews and Modernize Operations

1 min read
Source: Decrypt
FDA Introduces AI Platform to Accelerate Scientific Reviews and Modernize Operations
Photo: Decrypt
TL;DR

The FDA launched Elsa, a secure AI platform that significantly reduces task times and aims to modernize agency workflows, marking the beginning of several AI initiatives to enhance internal operations and better serve the public.

Share this article

Want the full story? Read the original reporting

Read on Decrypt